BioSpace News Archive

Business

Infinity Pharmaceuticals Provides Company Update and Reports Fourth Quarter and Full Year 2017 Financial Results

Infinity Pharmaceuticals Inc. announced its fourth quarter 2017 financial results and provided an update on the company, including its progress with IPI-549, a first-in-class oral immuno-oncology product candidate.

March 15, 2018
·
11 min read
Biotech Bay

Arcus Biosciences Announces Five Abstracts Accepted for Presentation at AACR 2018 Annual Meeting

Arcus Biosciences announced that five abstracts have been accepted for poster presentation at the American Association for Cancer Research (AACR) 2018 Annual Meeting to be held April 14-18, 2018 in Chicago, Illinois.

March 15, 2018
·
1 min read
Business

Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Reviews Business Progress

Catabasis Pharmaceuticals, Inc. reported financial results for the fourth quarter and full year ended December 31, 2017, and reviewed recent business progress.

March 15, 2018
·
8 min read
Business

Orthofix Announces Agreement to Acquire Spinal Kinetics

Orthofix International NV announced that it has entered into a definitive agreement to acquire Spinal Kinetics Inc., a privately held developer and manufacturer of artificial cervical and lumbar discs.

March 15, 2018
·
4 min read
Business

BioAmber Delays Filing of Annual Report on Form 10-K and Postpones Earnings Release and Conference Call for Fourth Quarter and Full Year 2017

BioAmber Inc. announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission (the “SEC”) regarding a delay in the filing of its Annual Report on Form 10-K for the fiscal year ended December 31, 2017.

March 15, 2018
·
1 min read
Business

BioScrip Provides Update on Annual Form 10-K Filing Status

BioScrip Inc. announced that it will be filing a Form 12b-25 with the U.S. Securities and Exchange Commission to automatically extend the date for filing its Annual Report on Form 10-K for the year ended December 31, 2017.

March 15, 2018
·
1 min read
Policy

Ferring Announces Positive Outcome of European Decentralised Procedure (DCP) for Testavan®, a Treatment for Men with Hypogonadism

Ferring Pharmaceuticals announced the positive outcome of the European Decentralised Procedure (DCP) for Testavan® (transdermal testosterone gel 2%).

March 15, 2018
·
4 min read
Drug Development

BerGenBio: Promising Data Highlighting Bemcentinib’s Potential to Improve Efficacy of Checkpoint Inhibitors to be Presented at AACR Annual Meeting

BerGenBio ASA announces that promising preclinical data with BerGenBio’s lead AXL inhibitor bemcentinib (formerly BGB324) will be featured at the 2018 American Association for Cancer Research (AACR) Annual Meeting on 14-18 April in Chicago, USA.

March 15, 2018
·
2 min read
Business

Medivir - The Nomination Committee´s Proposal for New Board of Directors to the Annual General Meeting 2018

Medivir AB announces the Nomination Committee’s proposal for a new Board of Directors to the Annual General Meeting 2018.

March 15, 2018
·
1 min read
Business

IQVIA Establishes Alliance with MuleSoft to Deliver Innovative Integration Technology to Life Sciences Companies

IQVIA announced at the eyeforpharma conference that it has formed a strategic alliance with MuleSoft.

March 15, 2018
·
3 min read